throbber
DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18.5”(w .5” glue tab) x 17”h (12”+5” pocket) @ crops with
`.125” bleed; FOLDED: 9”w x 12”h
`LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on disk.
`FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX PackagingBrochure
`Proof No.: 2—10/03/03 jl
`Page No. 1
`
`5912
`
`Outside Cover
`PRINTER SPREADS
`CMYK dieline
`
`For more information on enhanced packaging
`from Baxter, please contact your Baxter representative
`or call 1-800-422-9837.
`
`Looking for extra power
`Looking for extra power
`to overcome market challenges?
`to overcome market challenges?
`
`Connect to the resources you need.
`
`Baxter Healthcare Corporation, Route 120 and Wilson Road, Round Lake, IL 60073 USA Phone: 1-800-422-9837 www.baxterdrugdelivery.com
`
`©2003 Baxter Healthcare Corporation. All rights reserved. 10/03 920073 Printed in USA.
`BAXTER, VIAL-MATE, MINI-BAG PLUS, BIO-SET, ULTI-MATE, GALAXY, INTRAVIA and CLEARSHOT are trademarks of Baxter International Inc., its subsidiaries or affiliates.
`
`Connect to the resources you need.
`
`Sandoz Exhibit 1015 Page 1
`
`

`

`DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18”w x 12”h @ crops with .125” bleed;
`FOLDED: 9”w x 12”h LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on
`disk. FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX Packaging Brochure-Guts
`Proof No.: 2—10/03/03 jl
`Page No. 1
`
`5912
`
`Reader Spreads
`CMYK
`
`Discover solutions
`Discover solutions
`powered by enhanced
`powered by enhanced
`packaging.
`packaging.
`
`Getting to market with a new drug involves more than just proving clinical
`
`efficacy and safety. Increased competition, changing customer needs, and
`
`expanding global markets each present unique, new challenges.
`
`Think about it. Have you ever:
`• Launched in a crowded drug class and found it difficult to differentiate your
`
`product from the competition?
`• Been faced with compatibility issues in parenteral delivery?
`• Had difficulty finding a supplier that could support your needs globally and
`
`consistently meet your expectations?
`
`If you’re facing one or all of these issues, there’s a proven and reliable source for
`
`you to consider. Enhanced packaging from Baxter.
`
`Enhancements designed to build value.
`
`Baxter can help you address challenges like these with enhanced packaging.
`
`With Baxter as your partner, you can deliver unique solutions that will:
`• Improve market presence of your molecule
`
`• Overcome technical challenges in getting to market
`
`• Provide a reliable, high-quality supply
`
`Unique, enhanced packaging can offer
`
`solutions for challenges at any stage of your
`
`product’s life cycle. From initial product
`
`development all the way through patent
`
`expiry, partner with Baxter to create
`
`packaging solutions that maximize your
`
`product’s potential.
`
`Sandoz Exhibit 1015 Page 2
`
`

`

`DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18”w x 12”h @ crops with .125” bleed;
`FOLDED: 9”w x 12”h LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on
`disk. FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX Packaging Brochure-Guts
`Proof No.: 2—10/03/03 jl
`Page No. 1
`
`5912
`
`Reader Spreads
`CMYK
`
`Discover solutions
`Discover solutions
`powered by enhanced
`powered by enhanced
`packaging.
`packaging.
`
`Getting to market with a new drug involves more than just proving clinical
`
`efficacy and safety. Increased competition, changing customer needs, and
`
`expanding global markets each present unique, new challenges.
`
`Think about it. Have you ever:
`• Launched in a crowded drug class and found it difficult to differentiate your
`
`product from the competition?
`• Been faced with compatibility issues in parenteral delivery?
`• Had difficulty finding a supplier that could support your needs globally and
`
`consistently meet your expectations?
`
`If you’re facing one or all of these issues, there’s a proven and reliable source for
`
`you to consider. Enhanced packaging from Baxter.
`
`Enhancements designed to build value.
`
`Baxter can help you address challenges like these with enhanced packaging.
`
`With Baxter as your partner, you can deliver unique solutions that will:
`• Improve market presence of your molecule
`
`• Overcome technical challenges in getting to market
`
`• Provide a reliable, high-quality supply
`
`Unique, enhanced packaging can offer
`
`solutions for challenges at any stage of your
`
`product’s life cycle. From initial product
`
`development all the way through patent
`
`expiry, partner with Baxter to create
`
`packaging solutions that maximize your
`
`product’s potential.
`
`Sandoz Exhibit 1015 Page 3
`
`

`

`The power to overcome technical issues.
`Formulation problems can dramatically slow or stop your product development
`process—and block your path to market. The formulation experts at Baxter, working
`with a dedicated program management team, will develop packaging that solves your
`formulation problem, achieving key milestones and
`keeping drug development on track. Baxter has a
`broad portfolio of packaging solutions, for both small
`and large molecules, to help you overcome:
`
`The difficult molecule challenge.
`
`A late market entry for a cardiovascular drug required
`lengthy preparation before administration. Our answer?
`Baxter created a ready-to-use product in a non-PVC film
`container. The result? The only product in its class marketed
`in this convenient, premixed form. After achieving rapid
`market acceptance within 6 months, it became the delivery
`system of choice for this molecule.
`
`• Drug reconstitution difficulties
`• Drug stability and shelf-life challenges
`• Material incompatibility
`• Dosage or administration issues
`
`The power to consistently meet quality and supply expectations.
`Obviously, quality has always been top priority in health care. But in today’s market, you need to
`deliver quality within a dynamic, global marketplace. As your global manufacturing partner,
`Baxter offers both proven capability and capacity you
`can rely on.
`• Proven expertise—more than 20 years of
`experience and 1 billion enhanced packaging
`units manufactured
`• Global reach—marketing and manufacturing in
`27 countries
`• Full-service development and manufacturing,
`from clinical scale through full commercialization
`• Experienced project management team with a track
`record of achieving milestones
`
`A popular antibiotic was difficult to reconstitute and
`foamed during manufacturing. In addition, a vial shortage
`threatened stockouts in the market. Our solution? Baxter
`developed a proprietary formulation to support a ready-
`to-use option, then increased manufacturing capacity to
`deliver product to customers experiencing vial shortages.
`The result? The Ready-to-Use Premix unit volume grew
`78% over 3 years, representing approximately 50% of
`the total drug volume.
`
`Two problems, one solution.
`
`Whether you’re at launch, responding to a specific market demand, or simply looking for a
`secondary supplier, Baxter can be your reliable outsourcing solution.
`
`DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18”w x 12”h @ crops with .125” bleed;
`FOLDED: 9”w x 12”h LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on
`disk. FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX Packaging Brochure-Guts
`Proof No.: 2—10/03/03 jl
`Page No. 2
`
`5912
`
`Reader Spreads
`CMYK
`
`A powerful source to solve a multitude of challenges.
`A powerful source to solve a multitude of challenges.
`
`The power to improve market presence.
`Managing a product throughout its life cycle is a challenge, especially in a marketplace with
`many competitive products. Baxter’s enhanced packaging will differentiate your product,
`helping you achieve a competitive edge.
`In addition to differentiation, Baxter offers the power of an established, universal brand. Your
`customers already know the Baxter enhanced packaging portfolio, which leads to rapid
`acceptance, brand loyalty, and customer satisfaction. That’s because all of our systems are
`designed with your customers’ needs in mind, such as:
`
`•Safety. Baxter systems reduce the risk of medication errors and contamination.
`•Simplicity. Health care professionals rapidly accept easy-to-use systems with fewer
`preparation steps.
`•Savings. Cost efficiencies come from systems that save pharmacy and staff time, minimize
`components, and reduce drug waste.
`By anticipating and meeting those needs, you’ll optimize your market share and increase your
`return on investment over the life of the product.
`
`Penetration puzzle.
`
`The makers of a parenteral antibiotic were looking for a way to increase penetration
`in the hospital market, better compete against an existing enhanced system, and
`increase use of the oral drug form upon discharge. Our solution? Baxter partnered
`with the drug company to create a reconstitution kit that included a vial and the
`VIAL-MATE transfer device. It reduced the potential for waste and simplified the use
`for inpatient infusion, encouraging the transition to oral use. The result? A kit that
`helped the pharma partner achieve competitive system parity, meet customers’
`needs, and maintain growth expectations.
`
`Sandoz Exhibit 1015 Page 4
`
`

`

`The power to overcome technical issues.
`Formulation problems can dramatically slow or stop your product development
`process—and block your path to market. The formulation experts at Baxter, working
`with a dedicated program management team, will develop packaging that solves your
`formulation problem, achieving key milestones and
`keeping drug development on track. Baxter has a
`broad portfolio of packaging solutions, for both small
`and large molecules, to help you overcome:
`
`The difficult molecule challenge.
`
`A late market entry for a cardiovascular drug required
`lengthy preparation before administration. Our answer?
`Baxter created a ready-to-use product in a non-PVC film
`container. The result? The only product in its class marketed
`in this convenient, premixed form. After achieving rapid
`market acceptance within 6 months, it became the delivery
`system of choice for this molecule.
`
`• Drug reconstitution difficulties
`• Drug stability and shelf-life challenges
`• Material incompatibility
`• Dosage or administration issues
`
`The power to consistently meet quality and supply expectations.
`Obviously, quality has always been top priority in health care. But in today’s market, you need to
`deliver quality within a dynamic, global marketplace. As your global manufacturing partner,
`Baxter offers both proven capability and capacity you
`can rely on.
`• Proven expertise—more than 20 years of
`experience and 1 billion enhanced packaging
`units manufactured
`• Global reach—marketing and manufacturing in
`27 countries
`• Full-service development and manufacturing,
`from clinical scale through full commercialization
`• Experienced project management team with a track
`record of achieving milestones
`
`A popular antibiotic was difficult to reconstitute and
`foamed during manufacturing. In addition, a vial shortage
`threatened stockouts in the market. Our solution? Baxter
`developed a proprietary formulation to support a ready-
`to-use option, then increased manufacturing capacity to
`deliver product to customers experiencing vial shortages.
`The result? The Ready-to-Use Premix unit volume grew
`78% over 3 years, representing approximately 50% of
`the total drug volume.
`
`Two problems, one solution.
`
`Whether you’re at launch, responding to a specific market demand, or simply looking for a
`secondary supplier, Baxter can be your reliable outsourcing solution.
`
`DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18”w x 12”h @ crops with .125” bleed;
`FOLDED: 9”w x 12”h LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on
`disk. FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX Packaging Brochure-Guts
`Proof No.: 2—10/03/03 jl
`Page No. 2
`
`5912
`
`Reader Spreads
`CMYK
`
`A powerful source to solve a multitude of challenges.
`A powerful source to solve a multitude of challenges.
`
`The power to improve market presence.
`Managing a product throughout its life cycle is a challenge, especially in a marketplace with
`many competitive products. Baxter’s enhanced packaging will differentiate your product,
`helping you achieve a competitive edge.
`In addition to differentiation, Baxter offers the power of an established, universal brand. Your
`customers already know the Baxter enhanced packaging portfolio, which leads to rapid
`acceptance, brand loyalty, and customer satisfaction. That’s because all of our systems are
`designed with your customers’ needs in mind, such as:
`
`•Safety. Baxter systems reduce the risk of medication errors and contamination.
`•Simplicity. Health care professionals rapidly accept easy-to-use systems with fewer
`preparation steps.
`•Savings. Cost efficiencies come from systems that save pharmacy and staff time, minimize
`components, and reduce drug waste.
`By anticipating and meeting those needs, you’ll optimize your market share and increase your
`return on investment over the life of the product.
`
`Penetration puzzle.
`
`The makers of a parenteral antibiotic were looking for a way to increase penetration
`in the hospital market, better compete against an existing enhanced system, and
`increase use of the oral drug form upon discharge. Our solution? Baxter partnered
`with the drug company to create a reconstitution kit that included a vial and the
`VIAL-MATE transfer device. It reduced the potential for waste and simplified the use
`for inpatient infusion, encouraging the transition to oral use. The result? A kit that
`helped the pharma partner achieve competitive system parity, meet customers’
`needs, and maintain growth expectations.
`
`Sandoz Exhibit 1015 Page 5
`
`

`

`DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18”w x 12”h @ crops with .125” bleed;
`FOLDED: 9”w x 12”h LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on
`disk. FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX Packaging Brochure-Guts
`Proof No.: 2—10/03/03 jl
`Page No. 3
`
`5912
`
`Reader Spreads
`CMYK
`
`Connect to the resources you need.
`Connect to the resources you need.
`
`Why choose Baxter enhanced packaging? We offer the expertise, resources, capabilities, and
`services to help you use packaging to overcome your product challenges.
`
`Industry leadership.
`Since its introduction of the first commercial IV solution in glass bottles in 1931, Baxter has been an
`industry leader in proprietary packaging systems. With more than 50 parenteral product launches and
`more than 1 billion enhanced packaging products manufactured, we offer proven packaging experience.
`
`Comprehensive portfolio.
`We offer a global range of enhanced packaging that includes ready-to-use containers and ready-to-
`mix systems. All of our enhanced packaging systems are designed to meet your needs in order to:
`
`• Improve market presence of your molecule
`• Overcome technical challenges in getting to market
`• Provide a reliable, high-quality supply
`
`Full-service, global manufacturing capabilities.
`From formulation development to full-scale commercialization, Baxter delivers the quality
`manufacturing you expect—around the world. We also offer regulatory expertise and support at the
`local level to help secure the product approvals you need to get to market.
`
`With enhanced packaging, you can connect to a range of solutions…and the power you need to grow
`in the marketplace.
`
`Sandoz Exhibit 1015 Page 6
`
`

`

`DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18”w x 12”h @ crops with .125” bleed;
`FOLDED: 9”w x 12”h LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on
`disk. FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX Packaging Brochure-Guts
`Proof No.: 2—10/03/03 jl
`Page No. 3
`
`5912
`
`Reader Spreads
`CMYK
`
`Connect to the resources you need.
`Connect to the resources you need.
`
`Why choose Baxter enhanced packaging? We offer the expertise, resources, capabilities, and
`services to help you use packaging to overcome your product challenges.
`
`Industry leadership.
`Since its introduction of the first commercial IV solution in glass bottles in 1931, Baxter has been an
`industry leader in proprietary packaging systems. With more than 50 parenteral product launches and
`more than 1 billion enhanced packaging products manufactured, we offer proven packaging experience.
`
`Comprehensive portfolio.
`We offer a global range of enhanced packaging that includes ready-to-use containers and ready-to-
`mix systems. All of our enhanced packaging systems are designed to meet your needs in order to:
`
`• Improve market presence of your molecule
`• Overcome technical challenges in getting to market
`• Provide a reliable, high-quality supply
`
`Full-service, global manufacturing capabilities.
`From formulation development to full-scale commercialization, Baxter delivers the quality
`manufacturing you expect—around the world. We also offer regulatory expertise and support at the
`local level to help secure the product approvals you need to get to market.
`
`With enhanced packaging, you can connect to a range of solutions…and the power you need to grow
`in the marketplace.
`
`Sandoz Exhibit 1015 Page 7
`
`

`

`DOC INFO: CREATED IN QUARK XPRESS 4.1
`FINAL TRIM SIZE: FLAT: 18.5”(w .5” glue tab) x 17”h (12”+5” pocket) @ crops with
`.125” bleed; FOLDED: 9”w x 12”h
`LIVE GRAPHICS: Autoswap “LR” FPO files for hi-res on disk.
`FONTS: Adobe—Helvetica Neue, Goudy, Futura, Domestos, Meta
`
`TOPIN & ASSOCIATES, INC.
`676 N. St. Clair St.–Suite 2000
`Chicago, Illinois 60611-2991
`Tel: 312.645.0100 Fax: 312.645.0120
`impact@topin.com www.topin.com
`
`Baxter Drug Delivery
`PROMAXX PackagingBrochure
`Proof No.: 2—10/03/03 jl
`Page No. 1
`
`5912
`
`Outside Cover
`PRINTER SPREADS
`CMYK dieline
`
`For more information on enhanced packaging
`from Baxter, please contact your Baxter representative
`or call 1-800-422-9837.
`
`Looking for extra power
`Looking for extra power
`to overcome market challenges?
`to overcome market challenges?
`
`Connect to the resources you need.
`
`Baxter Healthcare Corporation, Route 120 and Wilson Road, Round Lake, IL 60073 USA Phone: 1-800-422-9837 www.baxterdrugdelivery.com
`
`©2003 Baxter Healthcare Corporation. All rights reserved. 10/03 920073 Printed in USA.
`BAXTER, VIAL-MATE, MINI-BAG PLUS, BIO-SET, ULTI-MATE, GALAXY, INTRAVIA and CLEARSHOT are trademarks of Baxter International Inc., its subsidiaries or affiliates.
`
`Connect to the resources you need.
`
`Sandoz Exhibit 1015 Page 8
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket